Table 2.
BMI | SBP | DBP | HDL-C | LDL-C | TG | FBP | HbA1C | hsCRP | |
---|---|---|---|---|---|---|---|---|---|
Calprotectin | |||||||||
R | 0.147 | 0.061 | 0.135 | −0.166 | −0.028 | 0.192 | 0.221 | 0.437 | 0.510 |
P | 0.177 | 0.577 | 0.215 | 0.129 | 0.796 | 0.077 | 0.041 | <0.001 | <0.001 |
BMI | |||||||||
R | 0.237 | 0.146 | 0.097 | 0.126 | −0.501 | 0.117 | 0.180 | 0.175 | |
P | 0.028 | 0.180 | 0.377 | 0.246 | 0.641 | 0.285 | 0.096 | 0.188 | |
SBP | |||||||||
R | 0.611 | 0.228 | 0.239 | −0.051 | 0.003 | 0.112 | −0.030 | ||
P | <0.001 | 0.036 | 0.027 | 0.641 | 0.982 | 0.303 | 0.823 | ||
DBP | |||||||||
R | 0.259 | 0.155 | −0.158 | 0.070 | 0.150 | 0.019 | |||
P | 0.017 | 0.153 | 0.146 | 0.523 | 0.169 | 0.887 | |||
HDL-C | |||||||||
R | 0.460 | 0.077 | 0.391 | 0.271 | −0.224 | ||||
P | <0.001 | 0.484 | <0.001 | 0.012 | 0.094 | ||||
LDL-C | |||||||||
R | 0.171 | 0.224 | 0.070 | −0.328 | |||||
P | 0.116 | 0.038 | 0.522 | 0.012 | |||||
TG | |||||||||
R | 0.587 | 0.324 | −0.047 | ||||||
P | <0.001 | 0.002 | 0.726 | ||||||
FBG | |||||||||
R | 0.729 | 0.207 | |||||||
P | <0.001 | 0.120 | |||||||
HbA1C | |||||||||
R | 0.203 | ||||||||
P | 0.127 |
Data were expressed as median (±IQR) and *mean (±SD). Mann–Whitney U and *Student’s t-test was used in comparison of 2 independent group. DM with neuropath group, DNP (+); DM without neuropathy group, DNP (−); Healthy control group, HC; Body Mass Index, BMI; Systolic blood pressure, SBP; Diastolic blood pressure; Fasting blood glucose; High density lipoprotein cholesterol, HDL-C; Triglyceride, TG; Low density lipoprotein cholesterol, LDL-C; High sensitive C reactive protein, hsCRP; Oral antidiabetic drug, OAD.